Look at the big picture with a MOBE Pharmacist. From your past health history to any new or recent treatments, a MOBE Pharmacist is here to help you put it all together. They help you build the best medication plan for your health goals by looking at all your prescriptions—across providers, pharmacies, and clinics—and listening to your concerns, as well as what has or hasn’t worked in the past. You’ll also learn more about how any over-the-counter drugs, dietary supplements, and/or herbal remedies fit into your treatment plan. Your pharmacist will partner with your MOBE Guide to optimize any lifestyle changes you might make to best support your medication situation. When access isn’t enough: Solving a paradox to serve healthcare’s hidden population. By: Chris Cronin, Chief Executive Officer https://www.mobeforlife.com/resources/when-access-isnt-enough-solving-a-paradox-to-serve-healthcares-hidden-population Promoting patient engagement to prevent readmissions By: Leslie Helou, Vice President of Guided Medication Programming https://www.mobeforlife.com/resources/promoting-patient-engagement-to-prevent-readmissions Our guests: Leslie Helou, PharmD, BCPS Vice President of Medication Strategies Leslie designs medication initiatives for MOBE participants that are hyper-personalized. These action plans address the complexity of each medication while highlighting the important role they can play when achieving health goals. She inspires her team to help others think critically about, understand, and get the best results possible from their medications while also making other healthy choices. Prior to joining MOBE, Leslie built a career at Upsher-Smith Laboratories, leading efforts to incorporate patient, provider, researcher, and advocacy group insights early in the pharmaceutical research and development process. Leslie received a doctorate in pharmacy from the University of Minnesota College of Pharmacy before completing a multi-year post-graduate residency in pharmaceutical care and leadership and becoming board certified in pharmacotherapy. She is passionate about mentoring and keeps a relationship with the University to provide unique, business-focused experiences to pharmacy students and graduates.  Chris Cronin Chief Executive Officer Chris leads corporate direction and strategy at MOBE and is motivated daily by guiding the team to do good together. He previously served as the company’s Chief Operating Officer. Prior to joining MOBE, Chris held various leadership positions at Medtronic in the Cardiac and Restorative Therapies Group, including European Business Director and leading the commercialization of the world’s first MR-Conditional Pacemaker. Chris has a BS in Accounting from St. John’s University and an MBA from The University of Notre Dame. He lives an active, healthy lifestyle and has completed 15 marathons and three Ironman triathlons, but still loves a big bowl of ice cream. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In 2013, Congress passed the Drug Supply Chain Security Act, often called the “track and trace” law, which is designed protect consumers against counterfeit drugs. In November 2020, new requirements for pharmacists took effect. To learn more about what pharmacists need to know, we spoke with Ilisa Bernstein, senior vice president for government affairs and pharmacy practice at APhA; and Leigh Verbois, director of the Office of Drug Security, Integrity and Response for the FDA’s Center for Drug Evaluation and Research.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

We're not talking about drugs made by Louis Vuitton or Dior, no. We're talking about drugs designed to circumvent existing laws by pushing the boundaries of chemistry. Brought to you by the hilarious Ivan Stewart, this episode will entertain as we explore the world of designer drugs. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at [email protected]. PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health, A special thanks to Kelly Kerr for creating the music used in the intro and outro. All Rights Reserved Sponsored by: UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Myopathy is a common reason for discontinuation of statin medications. The recent SAMSON study examined the nocebo effect and how this may bias patients towards treatment failure. How can clinicians overcome the nocebo effect? This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! Reference: Wood F, Howard J, Finegold J, et al. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects. N Engl J Med 2020; 383:2182-2184. DOI: 10.1056/NEJMc2031173 See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The efficacy of antiretroviral therapy has led to persons with HIV living a near-normal lifespan. But medications only work when used appropriately. The International Antiviral Society-USA Panel published updated recommendations for the treatment and prevention of HIV infections. Treatment of HIV may be distilled into a simple idea - two "nucs" and something else. Learn how to optimize care for your patients. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! Reference: Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel. JAMA. 2020;324(16):1651-1669. Available at: https://www.iasusa.org/2020/11/12/antiretroviral-drugs-treatment-prevention-hiv-infection-adults-2020-recommendations-of-the-international-antiviral-society-usa-panel/  The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Donald, “Sparky” Hedden, R.Ph., and the team at McCoy Tygart Drug in Sheridan, Arkansas, won the 2020 Good Neighbor Pharmacy of the Year Award.  Sparky shares examples of things he does that helped his pharmacy earn this award. McCoy Tygart comes in at about 10,000 feet, 2500 of it dedicated to pharmacy.  In this episode Sparky tells how his pharmacy has adopted an aggressive Medsync program that now boasts 1200 patients and how installing a big tent and hiring high school and college students to be runners allowed him to safely serve patients in this high volume pharmacy.    Sparky is joined by Robert Mosby, his GNP Business Coach who adds some details on things this remarkable pharmacy does.  This episode of Pharmacy CrossRoads is sponsored by Compliant Pharmacy Alliance(CPA), learn more here: https://members.compliantrx.com/  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Metal Gear is a series not known for realism, however the detail in the medicine and drugs portrayed in the game turn out surprisingly deep. Mickey Ferguson joins us again to deliver this funny and fascinating analysis of the drugs of Metal Gear.  This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at [email protected]. PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health, A special thanks to Kelly Kerr for creating the music used in the intro and outro. All Rights Reserved See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Whether you’ve worked your whole career building your business, inherited or purchased from family, or more recently acquired the business, at some point all owners start to think about the next chapters of their life and selling their business.  The world of pharmacy isn’t much different from other businesses in this sense, and it can be hard for an entrepreneur, visionary, and owner to start forecasting life without the business they’ve given so much of their time, energy, focus, and money. To say there is an emotional attachment may be an understatement.  While some owners can’t wait to dump their business, I’d be willing to bet the majority of pharmacy owners truly love their business, employees, and patients.  Being so engrained in the community, it’s hard for owners not to worry about their patients.  Owners worry about the level of care, or access to care, their patients may, or may not, have should they sell their location.  In some instances that worry for their staff and their community leaves owners holding onto the business much longer than maybe they initially wanted. Lear more:  https://www.rjhedges.com/blog/3-roads-to-sell-your-pharmacy  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Great Valley Publishing Company has partnered with the Pharmacy Podcast Network to deliver the best audio source of education, innovation, and evidence-based podcasts about medical cannabis. The CRx Podcast is the new podcast for the CRX Magazine: http://www.CRxMag.com  Great Valley Publishing Company has been serving health professionals for over 25 years. Our current B-to-B publications target specific audiences within several areas of health care — health information management, radiology, nutrition, social work, and aging.  For The Record, Radiology Today, Today's Dietitian, Social Work Today, and Today's Geriatric Medicine are each leaders in their respective fields. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

On December 18, 2020, the Food and Drug Administration authorized the emergency use of the Moderna vaccine, exactly one week after granting the same to the vaccine developed by Pfizer and BioNTech. Two days later, the Advisory Committee on Immunization Practices (ACIP) has issued its recommendations for the next two phases of vaccine allocation. Our guests are Michael D. Hogue, president of APhA, and a member of a working group of health care leaders that has been advising CDC on the rollout of the vaccine; and Stephan Foster. a member of ACIP, who has also served as a faculty member at the University of Tennessee’s School of Pharmacy and as a captain with the US Public Health Service. Resources referenced in this podcast: FDA: Provider Guidance for the Moderna Vaccine (pdf) FDA: Patient information about the Moderna Vaccine (pdf) ACIP: Recommendations for Allocation Phase 1b and 1c (pdf) See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The PUTTcast Episode 12: Looking Back on 2020 Join hosts PUTT Executive Director Monique Whitney, and Board President Scott Newman; with PUTT board members Lauren Young, Jeremy Counts, & Van Coble as they take a look back over the events of 2020 and discuss what this could mean for pharmacies in the upcoming year.  Join the Fight:  https://www.truthrx.org/rxrevolution.html  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Clostridioides difficile is an important cause of morbidity and mortality in the United States with over 500,000 infections annually. The Infectious Disease Society of America released a clinical quality measure focused on treatment of c diff in March 2020. A review of the diagnosis and treatment will help providers improve quality. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy Connect Podcast: PCSK9 Inhibitors Title: PCSK9 Inhibitors:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management Special guest: Joseph Saseen, PharmD Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy      Skaggs School of Pharmacy and Pharmaceutical Sciences     University of Colorado Anschutz Medical Campus Objectives Understand the role of PCSK9 inhibitors in the American Heart Association and the American College of Cardiology hyperlipidemia management guidelines Review the pertinent drug information and clinical benefits of the use of PCSK9 inhibitors in the treatment of hyperlipidemia. Describe the role of the pharmacist in patient education and counseling on PCSK9 inhibitors for the treatment of hyperlipidemia through motivational interviewing. CE LINK HERE: https://www.pharmacytimes.org/on-demand/pcsk9-inhibitors-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-with-hyperlipidemia-management PTCE - Pharmacy Times Continuing Education See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

On Dec. 10, 2020, the U.S. Supreme Court ruled 8-0 that an Arkansas law regulating how PBMs and pharmacies interact could be enforced, and was not preempted by federal law. With more than three dozen other states debating or passing such legislation, the ruling could have nationwide impact. The CEOs of national pharmacy organization were unanimous in hailing the decision. In this episode, three guests discuss the case: Rep. Buddy Carter (R-Georgia); John Vinson, CEO of the Arkansas Pharmacists Association; and Scott Knoer, Executive Vice President and CEO of the American Pharmacists Association. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

For over a century, the treatments and technologies used to treat diabetes have evolved. New tools are now available to aid in diabetes management and to help patients further manage and better control their glucose levels. 1,2 Through their recently announced collaboration, Dexcom and Lilly are at the forefront of enhancing diabetes care. 3 In this episode Dr. Chad Worz and guest speakers Deirdre Ibsen and Dr. Thomas Blevins discuss these important technological and therapeutic achievements over time, as well as 2 products available from Dexcom and Lilly and how they may benefit patients with diabetes. References:  Dexcom G6 Pro User Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/Dexcom-G6-Pro-User-Guide.pdf. Accessed October 12, 2020. Lyumjev [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC. Eli Lilly and Company. Lilly and Dexcom team up on new program to help improve diabetes management. https://provider.dexcom.com/products/dexcom-g6-pro/training-resources. Accessed October 12, 2020. Centers for Disease Control. National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed October 1, 2020. American Diabetes Association. Diabetes and Quality of Life. http://journal.diabetes.org/diabetesspectrum/00v13n1/pg48.htm. Accessed October 1, 2020. American Diabetes Association. Caring for the Caregiver. https://spectrum.diabetesjournals.org/content/17/1/37.full-text.pdf. Accessed October 15, 2020. Ali MK, Bullard KM, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013;369(3):287-288. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(suppl 1):S77-S88. Hirsch IB. History of Glucose Monitoring. https://professional.diabetes.org/sites/professional.diabetes.org/files/media/db201811.pdf. Accessed October 1, 2020. White JR. A brief history of the development of diabetes medications. Diabetes Spectr. 2014;27(2):82-86. Science History Institute. Frederick Banting, Charles Best, James Collip, and John Macleod. https://www.sciencehistory.org/historical-profile/frederick-banting-charles-best-james-collip-and-john-macleod. Accessed October 1, 2020. American Diabetes Association. Timeline. https://www.diabetes.org/resources/timeline. Accessed October 9, 2020. Humalog [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC. Selam J-L. Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol. 2010;4(3):505-513. American Association of Diabetes Educators. Insulin Injection Know-How. https://www.diabeteseducator.org/docs/default-source/legacy-docs/_resources/pdf/general/Insulin_Injection_How_To_AADE.pdf. Accessed October 1, 2020. Hyllested-Winge J, Jensen KH, Rex J. A review of 25 years’ experience with the NovoPen® family of insulin pens in the management of diabetes mellitus. Clin Drug Investig. 2010;30(10):643-674. Eli Lilly and Company. Lilly Launches KwikPen(TM) for Humalog(R) and Humalog Mixtures [press release]. https://investor.lilly.com/news-releases/news-release-details/lilly-launches-kwikpentm-humalogr-and-humalog-mixtures. Accessed October 12, 2020. American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(suppl 1):S66-S76. Garber AJ, Handelsman Y, Grunberger G, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary. Endocr Pract. 2020;26(1):107-139. Fonseca VA, Grunberger G, Anhalt H, et al. Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract. 2016;22(8):1008-1021. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603. Dexcom G6 Pro Unblinded Patient Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/Dexcom-G6-Pro-Unblinded-Patient-Guide.pdf. Accessed October 12, 2020. Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM. https://provider.dexcom.com/industry-news/fda-authorizes-dexcom-g6-pro. Accessed October 2, 2020. Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. 2017;317(4):371-378. Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365-374. Polonsky WH, Hessler D, Ruedy KJ, Beck RW. The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial. Diabetes Care. 2017;40(6):736-741. Pratley RE, Kanapka LG, Rickels MR, et al. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 2020;323(23):2397-2406. Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C. Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple daily injections of insulin: results from the DIAMOND trial. J Diabetes Sci Technol. 2017;11(6):1138-1146. Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. 2017;317(4):379-387. Frequently Asked Questions. https://provider.dexcom.com/products/dexcom-g6-pro/faqs. Accessed October 15, 2020. Dexcom Products: Dexcom G6 Pro. https://provider.dexcom.com/products/professional-cgm. Accessed October 15, 2020. How to Customize Alarm and Alerts. https://www.dexcom.com/faqs/how-to-customize-alarm-and-alerts. Accessed October 15, 2020. Trend Arrows and Treatment Decisions. https://s3-us-west-2.amazonaws.com/dexcompdf/HCP_Website/LBL015804+G6+Trend+Arrows+and+Treatment+Decisions.pdf. Accessed October 15, 2020. Why CGM? https://provider.dexcom.com/why-cgm. Accessed October 12, 2020. Pharmacy Coverage. https://provider.dexcom.com/pharmacy-coverage. Accessed October 12, 2020. Is There Reimbursement for Using Dexcom G6 Pro? https://provider.dexcom.com/faqs/there-reimbursement-using-dexcom-g6-pro. Accessed October 12, 2020. Hypoglycemia Unawareness. https://provider.dexcom.com/education-research/clinical-evidence/clinical-studies/real-time-continuous-glucose-monitoring-cgm. Accessed October 15, 2020. Garg SK, Wernicke-Panten K, Wardecki M, et al. Safety, immunogenicity, and glycemic control of insulin aspart biosimilar SAR341402 versus originator insulin aspart in people with diabetes also using insulin glargine: 12-month results from the GEMELLI 1 trial. Diabetes Technol Ther. 2020;22(7):516-526. Dexcom G6 Pro Blinded Patient Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/HCP_Website/Dexcom+G6+Pro+Resources/LBL017177+Rev+004+Artwork%2C+Dexcom+G6+Pro+Blinded+Patient+Guide+US_r5_WEB.pdf. Accessed November 24, 2020. Dexcom CLARITY Diabetes Management Software. https://www.dexcom.com/clarity. Accessed May 15, 2020. Blevins T, Zhang Q, Frias JP, Jinnouchi H, Chang AM. Randomized double-blind clinical trial comparing ultra rapid lispro with lispro in a basal-bolus regimen in patients with type 2 diabetes: PRONTO-T2D. Diabetes Care. Published online July 2, 2020. doi: 10.2337/dc19-2550. Klaff L, Cao D, Dellva MA, et al. Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: results from the 26-week PRONTO-T1D study. Diabetes Obes Metab. 2020;22(10):1799-1807. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Todays FutureDose.tech guest is Allen Flynn, PhD & PharmD,  Assistant Professor, Department of Learning Health Sciences at the University of Michigan.  It has been reported that 70% of pharmacists’ time is spent on non-cognitive activities such as medication distribution. As such, the industry recognizes that more automation is needed so that pharmacists and pharmacy technicians can spend more time on patient focused activities that improve outcomes. Allen Flynn, PhD & PharmD, is one of the industry trailblazers researching and building tools that will enable pharmacists to spend more time by the bedside. Listen in as David Berkowitz and Allen Flynn discuss some of the problems that need to be solved from a clinical and technical perspective in order to automate more non-value added pharmacy tasks. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Black Panther proves to be more medically accurate than you might think. In this episode, our hosts are joined by friend and classmate Justin Frederick to discuss the realism of the heart-shaped herb; the source of the Black Panther's powers. We discuss ayahuasca, why cat's always land on their feet, and whether or not Cal should watch "The Black Panther," (he should.) All that and more on Let's Pharmonize! This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at [email protected]. PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health, A special thanks to Kelly Kerr for creating the music used in the intro and outro. Audio from Black Panther owned by Disney Studios. All Rights Reserved This episode is sponsored by:  CEimpact: https://www.ceimpact.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Following the emergency authorization of the Pfizer-BioNTech COVID-19 vaccine we spoke with two pharmacy experts in immunization to talk about what it means for pharmacists. Our guests: Michael Hogue, president of the American Pharmacists Association, Dean of the Loma Linda University College of Pharmacy, and a member of a special work group of health care leaders advising CDC on the rollout of the COVID vaccine. Stephan Foster, PharmD, FAPhA, CAPT (Ret.), U.S. Public Health Service, and APhA liaison to the Advisory Committee on Immunization Practices.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The question of acetaminophen versus ibuprofen may finally be laid to rest. A recent meta-analysis compared the efficacy and safety of ibuprofen versus acetaminophen for the treatment of fever or pain in children younger than 2 years. Is there a drug of choice? Reference: Tan E, Braithwaite I, McKinlay CJD, Dalziel SR. Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(10):e2022398. doi:10.1001/jamanetworkopen.2020.22398 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Future of Pharmacy Podcast, presented by Omnicell Episode 2 Advocates for Safe IV Preparation Practices Share Their Inspiration Learn how a tragic medication error helped to inspire the formation of THRIV—a safety coalition comprised of healthcare providers, consumers and technology developers. THRIV seeks to protect patients from being harmed, and to protect caregivers from unwittingly doing harm—harm which too often stems from mistakes made when IVs are manually prepared. Our host: Ken Perez, Vice President, Healthcare Policy, Omnicell Guests:  Mark Neuenschwander, Founding Director, THRIV Derek Gillespie, BPharm, MBA, Pharmacy Operations Manager, Renown Health See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

What a year 2020 has been. One thing is certain: business will never be the same again. So get ready to turn the page because 2021 is just around the corner — and it’s bringing with it all sorts of new opportunities. No more of the negative and definitely no more of the old. It is time for us to collectively look ahead. In today’s episode, we’ll discuss how journalists filter the news, what’s ahead for The Corepreneur Podcast in 2021, and what 2020 looked like for a variety of business endeavors across healthcare. This episode of the Corepreneur Podcast is sponsored by CEimpact. Learn more about CEimpact's online Continuing Education platform designed for career driven & innovative pharmacists at http://www.CEimpact.com  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Myoshia Boykin-Anderson discusses how she started her first business, how spirituality and business intersect, and why her secret lake house is so important to her. “I do not let 'no' be the final answer for me." - Myoshia Boykin-Anderson. Learn more about this episode of The Corepreneur Podcast with Anne Arvizu at www.annearvizu.com/11  This episode of the Pharmacy Podcast is sponsored by UltiGuard Safe Pack UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast   See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of the Classy Chemist Podcast with Sarina Mughal we talk about optimal skin care & a pharmacist's insights.  Listen, learn, and share this very exciting episode introducing a fellow pharmacist and owner of a skincare brand inspired by his ethnicity and love for travel.  Sponsored by: Dilma Herbals Founder: Gaurav Gupta Website: https://dilmaherbals.co.uk/ Instagram: @dilmaherbals  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

These days, your patients may be wondering, "How many people touch these pills before I take them?!" COVID-19 has increased pressure on healthcare providers to consider the use of “touchless technology” and other best practices to reduce disease transmission and keep patients safe. This podcast episode will discuss consumer demand for 'no contact' medication packaging, and how you can differentiate your pharmacy and increase customer loyalty by providing safe, accurate, and untouched prescriptions. As compliance packaging becomes increasingly popular, pharmacy owners are starting to look at dispensing costs -- not in terms of drug wholesale costs, rebates and DIR fees -- but in terms of vials versus blisters, or vials versus pouches. After all, reimbursement doesn't change based on the packaging. The patients are prescribed the same NDCs, and their copay is the same regardless of whether the drugs go into a little amber bottle, a 7-day blister pack, or a strip of pouches labeled, ‘morning,’ ‘afternoon,’ and ‘evening.’ But what about your pharmacy costs, and specifically your dispensing costs -- including labor and materials -- for getting the scripts into the patients’ hands? Regular readers of our blog may remember we already conducted a deep dive into the cost of strip packaging consumables last year. Consumable costs for our RapidPakRx™ strip packaging system are demonstrably lower than competing systems.  Special Guests:  Joe Williams, Brisson Pharmacy Roberta Vining, Riley's Drugs See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In the never ending battle with COVID-19, new studies have demonstrated a role for IVIG in the treatment of acute COVID-19 pneumonia, the potential benefit of honey and black seed in mild to moderate COVID-19, and the efficacy of an mRNA vaccine. What does this all mean for current practice? Additional References: IVIG: Gharebaghi, N., Nejadrahim, R., Mousavi, S.J. et al. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial. BMC Infect Dis 20, 786 (2020). https://doi.org/10.1186/s12879-020-05507-4  Honey: Ashraf S, Ashraf S, Imran M, et al. Efficacy of honey and Nigella sativa against COVID-19: HNS-COVID-PK Trial. medRxiv 2020.10.30.20217364; doi: https://doi.org/10.1101/2020.10.30.20217364  Cleveland Clinic Hospitalization Risk for COVID-19 Positive Calculator: https://riskcalc.org/COVID19Hospitalization/  Cleveland Clinic Predict COVID-19 test result Calculator: https://riskcalc.org/COVID19/  This episode is accredited for CPE. Subscribe at CEimpact https://www.ceimpact.com/pharmacist and claim your CE today! The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Pennsylvania Pharmacists Association (PPA) Board of Directors has named Victoria E. Elliott, RPh, MBA, CAE as Chief Executive Officer.  Elliott will succeed Patricia A. Epple, CAE, who is retiring at the end of 2020. “Pat has been an outstanding leader of PPA for the last almost two decades,” said Chuck Kray, president of PPA. “She is leaving a strong organization in the hands of an equally strong successor. We are looking forward to welcoming Victoria Elliott.” Epple has been with PPA since 2002. As CEO, Elliott will blend her training as a registered pharmacist with her 24 years of experience in association management to lead PPA in its mission promoting the profession through advocacy, education, and communication to enhance patient care and public health. She will manage PPA operations, membership growth and engagement, and all program development and implementation. In addition, she will oversee PPA’s affiliated entities including its Educational Foundation, the Pennsylvania Pharmacists Care Network, and PharmPAC – PPA’s political action committee.  A Certified Association Executive since 2003, Elliott’s qualifications include alliance-building, volunteer engagement, board governance, leading legislative advocacy, and grassroots efforts to affect laws and regulations that critically impact healthcare professionals and the patients they serve. “I look forward to joining the PPA management team and am excited to work with my pharmacy colleagues and the PPA Board of Directors to advance the state of pharmacy practice across Pennsylvania,” said Elliott. Prior to this appointment, Elliott was the CEO of the Association for the Advancement of Wound Care (AAWC), where she led a management transition, implementation of a three-year strategic plan, a branding campaign, and the launch of a series of educational summits focused on critical wound care issues. She also served as Executive Director for the American Neurological Association, Dermatology Nurses’ Association, Attention Deficit Disorder Association, and the Society For Biomaterials at Association Headquarters, and was the Executive Director for the Pennsylvania Society of Health-System Pharmacists from 1998 to 2005. Before her career in association management, Elliott spent six years as a pediatric pharmacist in the Jefferson Health System, and two years as the Assistant Director of Pharmacy at Hahnemann University Hospital. In addition to her pharmacy degree from the Philadelphia College of Pharmacy, now part of the University of the Sciences, Elliott earned an MBA in Health and Medical Services from Widener University. She is a Past President of the Mid-Atlantic Society of Association Executives (MASAE) and the Delaware Valley Society of Association Executives. She is also a member of the American Society of Association, the organization that confers the CAE designation. Elliott is a recipient of the MASAE Service Award for her distinguished service to the Association and in 2001, was recognized by the Philadelphia College of Pharmacy as the Young Alumnus Award winner.  Ms. Elliott will begin her new role on December 1, 2020.  PSHP congratulates Ms. Elliott on this appointment and looks forward to working with her, and PPA, on Pennsylvania pharmacy issues.  Pennsylvania Society of Health System Pharmacists  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Everyone talks about clinical decision support—but what about ‘medication decision support’? Clinical decision support (CDS) gets a lot of attention, but what about “medication decision support?” Increasingly, health system leaders are putting this issue front and center, especially as it relates to medication alerts that are integrated into EHR and clinician workflows. It’s important that medication alerts improve safety and quality while also making clinicians’ jobs easier. If not properly executed, these alerts can become a burden rather than a decision support tool. In an interview, Anna Dover, PharmD, and Bob Katter can speak to best practices around medical decision support, including medication alerts:   Fit the medication decision support into the user’s workflow without interrupting them—and make the alerts actionable. Move alerts to the time when they are relevant and to the best person capable of understanding and making a decision about the risk/medication. Use decision support that incorporates patient characteristics. We are going to see that alerts and decision support that rely only on medication lists and nothing more specific from the patient will start to fade away. That traditional approach, although very sensitive, is not very specific. In other words, the alert was good at telling you about a potential risk, but not good about telling you whether this specific patient was at higher or lower risk. We know have the technical capability to leverage lab results, patient age, gender, diagnosis, and other factors to fire an alert when the risk is high—or automatically suppress an alert when the risk is low. Leverage analytics for better medication decision support. By looking at the data being generated through prescribing, we can make predictions about how a clinician or set of clinicians will respond to alert-tuning or modification. It’s possible to simulate and make educated guesses about whether an alert will have the intended effect and improve care, or whether it will cause additional burden to the prescriber. Medication decision support can also go a step further: This data can be leveraged to make specific predictions about a patient, such as quantifying their risk of opioid addiction—or even better, their risk of facing a whole host of adverse drug events. That determination may be based upon their genetics, co-morbidities, and current physical state. The future of medication decision support will focus on a combination of curated, evidence-based rules/knowledge and AI-driven pattern recognition. When we have better alerts, we can use analytics to prove that they work better; they can be installed side-by-side with traditional alerts to validate that an advanced system is safe and effective—ultimately enabling the removal of traditional alerts. Monitor the impact of deployments, get feedback, and respond, in order to optimize.  It’s important to closely manage and maintain your knowledge system to reflect evidence and pivot as needed. First Databank (FDB) is the largest drug database in the United States. Bob and Anna are in discussions with health systems, hospitals, and community and retail pharmacists on a daily basis and have in depth knowledge on pain points and opportunities related to the pharmacy industry across the healthcare landscape. Anna from a Pharm D’s perspective and Bob from a business leadership perspective. Guests: Anna Dover, PharmD, Director, Product Management, (FDB)  LinkedIn profile: https://www.linkedin.com/in/anna-dover-02137117/ Bob Katter, President of First Databank (FDB)  Bio on FDB website: https://www.fdbhealth.com/company/leadership/bob-katter LinkedIn profile: https://www.linkedin.com/in/bobkatter/ This episode was sponsored by First Databank  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Beyond the Sig, Brooke Kulusich, a third-year student pharmacist at the University of Pittsburgh School of Pharmacy, sits down with Melissa S. McGivney, PharmD, FCCP, FAPhA who serves as Associate Dean for Community Partnerships and Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. As a national leader in advancing  pharmacist-provided patient care in the community for 20 years, Dr. McGivney shares her perspective on the progress our profession has made and the challenges that lie ahead. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Medication adherence has proven challenging for many individuals during the coronavirus pandemic. For all the convenience offered by virtual visits, they make it more difficult to administer injections or assess how patients are responding to medication. Difficulty obtaining refills or necessary lab work can be barriers to medication adherence, as well. Care coordination is especially important now, says Dr. Ehret, who also suggests that providers consider giving patients extra refills when warranted—and check in on patients most at risk for medication nonadherence. Featuring: Megan Ehret, PharmD, MS, BCPP Associate Professor at the University of Maryland School of Pharmacy and PsychU Pharmacist Corner Advisor Joseph Cirrincione, PharmD, MBA Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc. Megan Ehret, PharmD, MS, BCPP, is Associate Professor in the Department of Pharmacy Practice & Science at the University of Maryland School of Pharmacy. A board-certified psychiatric pharmacist, she is also PsychU’s Pharmacist Corner Section Advisor. Joseph Cirrincione, PharmD, MBA, is Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. Speakers are paid consultants or employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In January 2020, a front page article in the New York Times by Ellen Gabler hit the pharmacy profession like a thunderbolt: How Chaos at Chain Pharmacies is Putting Patients at Risk. For many pharmacists, every word of it rang true - and propelled Wes Hickman from obscurity to pharmacy celebrity. Dr. Hickman’s posts on the social media platform Reddit, announcing his decision to go out on his own, caught the attention of the NY Times. His experiences gave voice to the frustrations and fears of many like him. He is now the sole proprietor of an independent pharmacy bearing his name in Leland, N.C., just outside of Wilmington. We spoke with him recently on a weekday morning, as he was preparing to open his pharmacy and serve the people of the town where he was raised and still lives with his young family.  Here's the original NYT Article featuring Wes Hickman:  https://www.nytimes.com/2020/01/31/health/pharmacists-medication-errors.html  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

We welcome our newest host, pharmacy student at the University of Pittsburgh School of Pharmacy ‘22 Ms. Brooke E. Kulusich Brooke mentions: "Throughout pharmacy school, my passion for patient care has remained the driving force in my career. I have gained a deep appreciation for the vital role of pharmacists in the community and have been inspired to scale my impact beyond the individual patient level. As one of the most highly-regulated industries, pharmacy presents a unique opportunity to engage clinicians in shaping policies that carry our profession forward. Through Gavel & Pestle, I hope to share my passion for the intersection of healthcare and the law and look forward to learning alongside our audience through conversations with experts. As a third-year student pharmacist, I am interested in a career in pharmacy law or association management that would enable me to leverage my patient care experiences to advance policy decisions and improve patient access to care. Upon graduation, I hope to pursue a clinical or commercial role in a healthcare, government, private sector or public sector leadership position."  Contact us today for a Gavel & Pestle Podcast episode appearance.  Today's episode is sponsored by CEimpact:   https://www.ceimpact.com/marketplace  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

"Twenty minutes is an eternity in our business, where literally every second counts," says Priyank, who owns three pharmacies in New York: one in the Bronx and two in Yonkers. "The Real-Time Prescription Benefit solution has essentially solved this problem for us, while at the same time, providing a much better experience for our patients." Priyank says his road to pharmacy ownership felt inevitable. "I've always wanted to help people, and I've always had an interest in health care." That's why instances of patients having to leave the pharmacy without their medications were especially heartbreaking. "This was happening multiple times per day, to maybe 20% of our patients, and the logical result was an increase in non-adherence." Priyank's trio of pharmacies includes Felicity Pharmacy in the Bronx, and Getty Square Pharmacy and Health Rx Pharmacy in Yonkers. Both Felicity and Getty Square serve patients who mostly rely on Medicare and Medicaid. Priyank Patel owners of 3 pharmacies: Felicity Pharmacy in the Bronx, and Getty Square Pharmacy and Health Rx Pharmacy in Yonkers. Both Felicity and Getty Square serve patients who mostly rely on Medicare and Medicaid. Stated in the blog MMS Blog https://www.micromerchantsystems.com/blogdetail/big-savings-in-the-big-city Surescripts Blog: https://surescripts.com/news-center/intelligence-in-action/price-transparency/big-savings-in-the-big-city/ See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Atopic Dermatitis is not extensively taught in pharmacy curriculum. With several international medical societies publishing updated guidelines and newly approved medications, it's time for a review. Clinicians can learn ways to help treat patients under the skin. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Medical PotCast host Joe Friedman interviews Cannabis Industry Consultant Shanna Perry. For the last 10 years, Shanna Perry has been entrenched in the American cannabis industry. Ms. Perry has lived and worked in West Palm Beach, Los Angeles, Denver, New York City and in Las Vegas. After earning her degree in audio engineering and broadcasting, Ms. Perry served as Director of Events for five CBS AM/FM radio stations. After leaving that position in 2010 she became interested in learning more about the cannabis industry and how she could position herself for a successful career in the cannabis space. Motivated to self educate, she lived in Denver, NYC, FL, and Las Vegas. Each move brought new knowledge, new experiences, and a greater understanding of economics and the cannabis industry. In 2014, recognizing Nevada was positioned for enormous growth in both the medical and recreational cannabis channels, Ms. Perry took up residence in Las Vegas and became an original member of the Las Vegas Medical Marijuana Association. Pioneering herself into the industry’s foundation, she was the first professional to successfully present and sell mainstream advertisers to a leading, Nevada-based, medical cannabis lifestyle publication. She moved easily from media to advising, honing her brand, SHANNABIS, at conventions and within the industry. Strategically using social media platforms enabled her to build her contact list along with her brand. Within three years, she became one of Las Vegas’ most influential and trusted advocates for cannabis. As a bona fide consultant on all aspects of cannabis, Ms. Perry has served as an advisor to government regulators, business owners, law enforcement, physicians, and attorneys globally. She is known for her honesty, vitality, and passion for the cannabis industry. Her well-roundedness and education, coupled with her personal and professional experiences, are the cornerstones of SHANNABIS. Making her truly, one of the cannabis industries’ most valuable resources. This episode is sponsored by UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Genetic mutations can result in anything from different hair colors to conditions like muscular dystrophy or cystic fibrosis, but did you know that the hands of fate can also dole out genetic superpowers? In this episode, our non-GMO hosts discuss three genetic mutations that result in abilities some consider to be... unnatural. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at [email protected]. PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,A special thanks to Kelly Kerr for creating the music used in the intro and outro.Additional music and sounds by FesliyanstudiosAll Rights Reserved See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The future of healthcare is precision dosing of medications guided by biosensors and other patient specific factors. The future of community pharmacy may include experts in 3D printing of medications who are remotely monitoring populations and crafting precise doses. Alvaro Goyanes, is the Co-Founder and Director of Development for FabRx a medication 3D printing company. FabRx has created user friendly software, a knowledge base of excipients and a 3D printer, MediMaker, so that pharmacists and Pharma can unlock the power of this novel technology. Listen in as David Berkowitz and Alvaro talk about use cases, challenges and the future of medication 3D printing.   Sponsored by UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The opioid epidemic is helping reduce prescriptions for opioid-based pharmacotherapy. However, parallel to this drop has been an increase in gabapentin and pregabalin prescriptions.  Why has this occurred and what should the clinician know about this phenomenon? Additional Resources/References: Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016. Zhou L, Bhattacharjee S, Kwoh CK, Tighe PJ, Malone DC, Slack M, Wilson DL, Brown JD, Lo-Ciganic WH. J Clin Med. 2019 Dec 29;9(1):83. doi:10.3390/jcm9010083. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Beyond the Sig, Brooke Kulusich, a third-year student pharmacist at the University of Pittsburgh School of Pharmacy, chats with Deborah Bowers, pharmacist and owner of Yorkville Pharmacy in York, South Carolina, and Cheri Schmidt, Director of Clinical Pharmacy at Medicap Pharmacy in Ames, Iowa. These CPESN luminaries talk medication synchronization, expanding the roles of pharmacy technicians, immunizations, and diabetes management to kick off a new progression of Flip the Pharmacy. https://www.papharmacists.com/page/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

All in for Specialty: How to Make Lasting Change in Patients’ Lives through Industry Standards and Guidance.” Participants are: Lee Ann Stember, President & CEO of NCPDP Sheila Arquette, President & CEO of National Association of Specialty Pharmacy Sponsored by: UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Listen in as our panel of independent pharmacy owners engages in a no-holds-barred discussion that addresses rural pharmacy to Wall Street, pharmacy education to politics, and everything in-between. Host: Monique Whitney Special Guests: Deborah Keaveny, Dave Bagot, Jeremy Counts, Nathan Mair See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, I discuss the unique challenges of 2020, how to make an exit strategy, and how to take this time to improve your business. “We're here to tell you, I jumped off the proverbial cliff. I flatlined. And here's how I bounced back.” – Anne Arvizu Learn more about this episode of The Corepreneur Podcast with Anne Arvizu at www.annearvizu.com/10  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Occupation Station, Dr. Kelly Cycon takes us from her early days as a lab technician at ZeptoMetrix, then called Cellular Products, to her current role as Director of Virology. Becoming frustrated at her inability to troubleshoot problems that were coming up, Dr. Cycon, at the encouragement of the company’s president, she made the choice to enroll in graduate school. Listen now to hear more about Dr. Cycon’s journey. Kelly Cycon, Ph.D, Director of Virology; Biotechnology & Infectious Disease ZeptoMetrix Corporation  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Sodium Glucose Co-Transporter-2 Inhibitors, a medication class for the treatment of diabetes, is now showing benefits in other medical conditions, like heart failure and kidney disease. Is this a class effect? Additional Resources/References: McGuire DK, Shih WJ, Cosentino F, et al. Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis . JAMA Cardiol. Published online October 07, 2020. doi:10.1001/jamacardio.2020.4511 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!   See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

APhA President Michael D. Hogue talks with distinguished vaccine expert John Grabenstein about the two leading COVID-19 vaccine candidates. They discuss characteristics of each vaccine and the implications for delivery and dispensing. Excerpted from the Nov. 5 episode of APhA’s weekly webinar on COVID-19. Listeners are invited to download a PDF copy of the webinar slides that are referenced in the episode.  APhA COVID-19 Resources: Know the Facts  https://www.pharmacist.com/coronavirus/practice-resources  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Steve Hoffart, PharmD, operates a truly amazing pharmacy.  Magnolia Pharmacyis a 5000+ square foot facility in Magnolia, TX , about twenty-five miles north of Houston.  Hoffart is a true innovator, successfully  jumping into point-of-care testing 4 or 5 years ago. He also does compounding, successfully stocks and sales professional grade nutraceuticals.  In this episode of Pharmacy CrossRoads I talk with Steve and he shares a little bit about how he got into both of these areas.  Steve and I are also joined by Jenni Zilka, Senior Vice President of the Good Neighbor Pharmacy and the two of them jump in a bit deeper on how Steve has used social media to support all the various services his pharmacy provides.  Here’s your chance to learn from two experts on ways you can make better use of your social media opportunities.  Learn more about Community Pharmacy partners at Good Neighbor Pharmacy  https://www.mygnp.com/  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Future of Pharmacy Podcast, presented by Omnicell Every day it seems, health system pharmacy leaders face new challenges. Learn how the Autonomous Pharmacy is intended to simplify medication management, and enable pharmacists and other clinicians to practice at the top of their licenses. Host: Ken Perez Vice President, Healthcare Policy, Omnicell Guests: Jennifer Tryon, PharmD, MS, FASHP Associate Vice President and Chief Pharmacy  Officer, Wake Forest Baptist Health Jim Stevenson, PharmD, FASHP, FFIP Vice President, Medication System Strategy, Omnicell See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

World Diabetes Day (WDD) was created in 1991 by IDF and the World Health Organization in response to growing concerns about the escalating health threat posed by diabetes. World Diabetes Day became an official United Nations Day in 2006 with the passage of United Nation Resolution 61/225. It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922. WDD is the world’s largest diabetes awareness campaign reaching a global audience of over 1 billion people in more than 160 countries. The campaign draws attention to issues of paramount importance to the diabetes world and keeps diabetes firmly in the public and political spotlight. The World Diabetes Day campaign aims to be the: Platform to promote IDF advocacy efforts throughout the year. Global driver to promote the importance of taking coordinated and concerted actions to confront diabetes as a critical global health issue The campaign is represented by a blue circle logo that was adopted in 2007 after the passage of the UN Resolution on diabetes. The blue circle is the global symbol for diabetes awareness. It signifies the unity of the global diabetes community in response to the diabetes epidemic. Every year, the World Diabetes Day campaign focuses on a dedicated theme that runs for one or more years. The theme for World Diabetes Day 2020 is The Nurse and Diabetes. Messaging and materials will start to be made available during the second quarter of 2020. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mental Health has hit its highest peak and yet there is such a stigma. We are dealing with the greatest mental health crisis ever and it’s so important to keep spreading awareness and education. Today we invite Dr. Bela Patel, PharmD and Dr. Deepti Gandhi, MD to talk about Mental Health on our series. Both of these health care providers have over 20 years of excellence in their fields. Dr. Bela Patel, PharmD is a Pharmacist and a Holistic Health Coach who uses her medical background and her passion for wellness to help her clients with simple yet powerful tools to address both mental and physical health conditions.  Dr. Deepti Gandhi, MD is a Family Medicine Physician who has a interest in lifestyle medicine. She believes that mental health is integral to an overall sense of well-being. Dr. Gandhi is passionate about empowering her patients to take control of their own health and wellness. Please follow them on Instagram: @wholisticpharmacist @drg_lifestylemd  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices